In partnership with Neuromod Prize, NIH, and Luminary Labs
Imagine if we could treat nearly any condition in the body through precise regulation of the nervous system. The Neuromod Prize is a $9.8 million competition from NIH’s SPARC program to accelerate the development of targeted neuromodulation therapies that could do just that. Come and see the Neuromod Prize finalists who are competing for a share of the $5 million Phase 3 prize pool for live presentations of their groundbreaking solutions. These innovators are bringing bioelectronic medicine closer to patients, offering new hope to millions battling chronic conditions.
The Neuromod Prize finalists:
- Anthony F. DiMarco, M.D. - High-frequency spinal cord stimulation reduces respiratory tract infections and improves bowel management in people with neurological impairment
- Juniper Biomedical - Highly precise, micro-implantable neuromodulation to treat stress urinary incontinence, overactive bladder and fecal incontinence
- University of Louisville Research Foundation Inc. - StimXS, neuromodulation of the lumbosacral spinal cord, automatically regulates cardiovascular, respiratory, and urinary
systems after spinal cord injury
- University of Pittsburgh Department of Urology - A novel multi-channel implantable device for sacral-pudendal neuromodulation to treat bladder, bowel, and sexual
disorders